i-manager Publications

Addressing Bioprinting Challenges in Tissue Engineering

Sri Manoj Kumar N.*, Atheena Milagi Pandian S.**, Rashika Murugan***, Sudherson M.****

*-****Atheenapandian Private Limited, Chennai, Tamil Nadu, India.

Periodicity:April - June'2024
DOI : https://doi.org/10.26634/jms.12.1.20880

Abstract

This paper discusses the current challenges and potential solutions in the field of bioprinting tissues and organs. It highlights that most bioprinted tissues are small, composed of few cell types, lack vascular systems, and have limited functionality. This paper emphasizes the need to develop methods to obtain various functional cell types, create vascular systems for nutrient delivery, and enhance the size and capabilities of 3D-printed tissue structures. Additionally, it explores the advancements in nanorobots in the medical field, focusing on their unique properties and applications in various medical areas like cancer, cardiology, and neurology.

Keywords

Bioprinting, Tissue Engineering, Vascular System, Biocompatible, Bio Ink, Vascularization, Nanorobots, 3D- Printed Tissue Structures.

How to Cite this Article?

Kumar, N. S. M., Pandian, S. A. M., Murugan, R., and Sudherson, M. (2024). Addressing Bioprinting Challenges in Tissue Engineering. i-manager’s Journal on Material Science, 12(1), 1-11. https://doi.org/10.26634/jms.12.1.20880

References

[1]. Brown, D. A., MacLellan, W. R., Laks, H., CY Dunn, J., M. Wu, B., & Beygui, R. E. (2007). Analysis of oxygen transport in a diffusion limited model of engineered heart tissue. Biotechnology and Bioengineering, 97(4), 962-975.

[2]. Criswell, T., Swart, C., Stoudemire, J., Brockbank, K., Floren, M., Eaker, S., & Hunsberger, J. (2022). Shipping and logistics considerations for regenerative medicine therapies. Stem Cells Translational Medicine, 11(2), 107-113.

[3]. De Coppi, P., Bartsch Jr, G., Siddiqui, M. M., Xu, T., Santos, C. C., Perin, L., & Atala, A. (2007). Isolation of amniotic stem cell lines with potential for therapy. Nature Biotechnology, 25(1), 100-106.

[4]. Huang, G., Wang, L., Wang, S., Han, Y., Wu, J., Zhang, Q., & Lu, T. J. (2012). Engineering three-dimensional cell mechanical microenvironment with hydrogels. Biofabrication, 4(4), 042001.

[5]. Jafarkhani, M., Salehi, Z., Aidun, A., & Shokrgozar, M. A. (2019). Bioprinting in vascularization strategies. Iranian Biomedical Journal, 23(1), 9-20.

[6]. Jain, R. K., Au, P., Tam, J., Duda, D. G., & Fukumura, D. (2005). Engineering vascularized tissue. Nature Biotechnology, 23(7), 821-823.

[7]. Jovic, T. H., Combellack, E. J., Jessop, Z. M., & Whitaker, I. S. (2020). 3D Bioprinting and the Future of Surgery. Frontiers in Surgery, 7, 609836.

[8]. Kačarević, Ž. P., Rider, P. M., Alkildani, S., Retnasingh, S., Smeets, R., Jung, O., & Barbeck, M. (2018). An introduction to 3D bioprinting: Possibilities, challenges and future aspects. Materials, 11(11), 2199.

[9]. Khalil, A. S., Jaenisch, R., & Mooney, D. J. (2020). Engineered tissues and strategies to overcome challenges in drug development. Advanced Drug Delivery Reviews, 158, 116-139.

[10]. Lovett, M., Lee, K., Edwards, A., & Kaplan, D. L. (2009). Vascularization strategies for tissue engineering. Tissue Engineering Part B: Reviews, 15(3), 353-370.

[11]. Skardal, A., Zhang, J., McCoard, L., Xu, X., Oottamasathien, S., & Prestwich, G. D. (2010). Photocrosslinkable hyaluronan-gelatin hydrogels for two-step bioprinting. Tissue Engineering Part A, 16(8), 2675-2685.

[12]. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131(5), 861-872.

[13]. Tibbits, S. (2012). Design to self assembly. Architectural Design, 82(2), 68-73.

[14]. Wagner, W., Horn, P., Castoldi, M., Diehlmann, A., Bork, S., Saffrich, R., & Ho, A. D. (2008). Replicative senescence of mesenchymal stem cells: A continuous and organized process. PloS One, 3(5), e2213.

[15]. Wang, Y., Kankala, R. K., Ou, C., Chen, A., & Yang, Z. (2022). Advances in hydrogel-based vascularized tissues for tissue repair and drug screening. Bioactive Materials, 9, 198-220.

[16]. Wu, W., DeConinck, A., & Lewis, J. A. (2011). Omnidirectional printing of 3D microvascular networks. Advanced Materials, 23(24), 178-183.

[17]. Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., & Thomson, J. A. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science, 318(5858), 1917-1920.